CN1192369A - Medicine for treating cirrhosis - Google Patents

Medicine for treating cirrhosis Download PDF

Info

Publication number
CN1192369A
CN1192369A CN98105026A CN98105026A CN1192369A CN 1192369 A CN1192369 A CN 1192369A CN 98105026 A CN98105026 A CN 98105026A CN 98105026 A CN98105026 A CN 98105026A CN 1192369 A CN1192369 A CN 1192369A
Authority
CN
China
Prior art keywords
radix
rhizoma
medicine
angelicae sinensis
long
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN98105026A
Other languages
Chinese (zh)
Inventor
孟福厚
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN98105026A priority Critical patent/CN1192369A/en
Publication of CN1192369A publication Critical patent/CN1192369A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention discloses a kind of traditional Chinese medicine for treating liver cirrhosis, it consists of root of membranousmilk vetch, capillary artemisia, root of red-rooted salvia, unpeeled root of herbaceous peony, arrowhead etc. 19 traditional Chinese medicinal herbs and is made into concentrated pills or capsules or powder etc. Chinese proprietary medicine through the ordinary traditional Chinese medicinal prepn. method. Said medicine can prolong the survival rate of patients of cancer of liver and ascites due to liver cirrhosis about 3-10 years.

Description

A kind of medicine for the treatment of liver cirrhosis
The present invention relates to a kind of Chinese medicine medicine for the treatment of liver cirrhosis.
Cirrhosis is a common frdquently encountered disease clinically after the hepatitis, is to cause the principal element of sending out canceration of hepatic cell.At present, whole world pathogenesis of cirrhosis rate is 2.5~3.5%, there is every year the people more than 400,000 to die from portal hypertension syndrome (upper gastrointestinal hemorrhage and/or ascites), also accounts for more than 4.5% of internal medicine number of hospitalized, and be the trend that increases year by year at the sickness rate of China's liver cirrhosis.Now the treatment of primary disease still there is not breakthrough.Main medicine, as: inosine, glucuronolatone, albumin, cellular energy mixture, compound amino acid supplement etc., still unsatisfactory to the cure rate and the alleviation complication that improve liver cirrhosis, treatment to cirrhotic ascites is corrected measures such as water salt through bed, limit sodium, spironolactone, diuretic, albumin, success rate only is 60%, acts on of short duration.
Reflecting to do has the problem that exists in the Drug therapy liver cirrhosis now, the purpose of this invention is to provide the Chinese medicine medicine of a kind of antiviral and the interior fibrosis of inhibition liver, mediation microcirculation, enhancing body immunity, minimizing alleviation liver cirrhosis.
Chinese medicine medicine of the present invention is made up of 19 flavor Chinese medicines such as the Radix Astragali, ZANGYINCHEN, Radix Salviae Miltiorrhizae, Radix Paeoniae Rubra, the Rhizoma Atractylodis Macrocephalae, Carapax Trionycis pearl, Rhizoma sagittariae sagittifoliae, OYSTER EXTRACT CAPSULE, Rhizoma Polygoni Cuspidati, Polyporus, long-pending reality, Rhizoma Cyperi, Radix Angelicae Sinensis, Radix Bupleuri, Semen Persicae, Colla Corii Asini, eupolyphaga, stir-fry Semen Pharbitidis, Radix Et Rhizoma Rhei (parched).
Pharmaceutical compositions of the present invention forms (weight ratio) scope: black ugly 1.8~2.7% rhubarb,torrefieds, 0.9~2.7% each the component summation of the Radix Astragali 5.3~16.0% Tibetan oriental wormwoods, 5.3~16.0% reds sage root 5.3~13.3% radix paeoniae rubrathe, 2.7~13.3% bighead atractylodes rhizomes 5.3~10.7% turtle shell pearls, 5.3~10.7% arrowheads 5.3~10.7% OYSTER EXTRACT CAPSULEs, 5.3~10.7% giant knotweeds 5.3~10.7% umbellate pore furgus, 2.7~5.3% long-pending real 2.7~5.3% rhizoma cyperis 2.7~5.3% Radix Angelicae Sinensis, 1.8~5.3% radix bupleuri 1.8~2.7% peach kernels, 1.8~2.7% donkey-hide gelatin 1.8~2.7% soil units, 1.8~2.7% stir-frys is 100%.
The optimal drug composition forms (weight ratio): black 2.0~2.5% rhubarb,torrefieds, 1.5~2.0% each the component summation of the Radix Astragali 8.6~12.6% Tibetan oriental wormwoods, 8.6~12.6% reds sage root 7.0~11.0% radix paeoniae rubrathe, 6.0~9.0% bighead atractylodes rhizomes 6.5~9.5% turtle shell pearls, 6.5~9.5% arrowheads 6.5~9.5% OYSTER EXTRACT CAPSULEs, 6.5~9.5% giant knotweeds 6.5~9.5% umbellate pore furgus, 3.5~4.5% long-pending real 3.5~4.5% rhizoma cyperis 3.5~4.5% Radix Angelicae Sinensis, 3.2~4.0% radix bupleuri 2.0~2.5% peach kernels, 2.0~2.5% donkey-hide gelatin 2.0~2.5% soil units, 2.0~2.5% stir-frys are 100%.
Use the prescription of drug component of the present invention, adopt common Chinese medicine processing method and preparation process, can be made into Chinese patent medicines such as concentrated pill, capsule and electuary.
Use medicine of the present invention to use clinically, give full play to the comprehensive function of each component of Chinese medicine medicine, on effect, demonstrate unique polytropism and indication widely, to improving and adjusting body's immunity and suppress liver inner cellulose hypertrophy, improve the circulation of liver inner blood, prevent hepatic necrosis, promote hepatocellular reparation and regeneration, make the liver and spleen retraction of enlargement, ascites is ended development and is eliminated, and has played good effect.Take through clinical 58 routine cirrhotic ascites patients, effective percentage to liver, splenomegaly is respectively 88.6% and 90.6%, in vain, globulin (A/G) ratio inversion rate is 92.8%, portal hypertension syndrome (upper gastrointestinal hemorrhage and/or ascites) effective percentage is 100%, it is fast to fall enzyme (GPT), can end pathological development effectively, improves General Symptoms, find that through the CT check this medicine has the distinguished service of stronger inhibition hepatoma carcinoma cell disintegrate fragmentation, so can be used for the treatment of hepatocarcinoma.Use this medicine, the survival rate of cirrhotic ascites and liver cancer patient was improved 3~10 years, life quality is obviously improved.
Embodiment: carrying out concentrated pill of the present invention when producing, its compound method is, each component drug is cleaned, and it is qualified all to concoct, and weighs by recipe ingredient and assorts; Crushing screening then; Through liquor (except that Carapax Trionycis pearl and Colla Corii Asini), leaching medicinal liquid; Add Carapax Trionycis pearl fine powder and donkey-hide gelatin fine powder again and mix, be condensed into ball, cold drying, polishing, it is stand-by to bottle.

Claims (2)

1, a kind of by the Radix Astragali, ZANGYINCHEN, Radix Paeoniae Rubra, Radix Salviae Miltiorrhizae, the Rhizoma Atractylodis Macrocephalae, the Carapax Trionycis pearl, Rhizoma sagittariae sagittifoliae, OYSTER EXTRACT CAPSULE, Rhizoma Polygoni Cuspidati, Polyporus, long-pending real, Rhizoma Cyperi, Radix Angelicae Sinensis, Radix Bupleuri, Semen Persicae, Colla Corii Asini, eupolyphaga, fry the Chinese medicine medicine of the treatment liver cirrhosis of Semen Pharbitidis and Radix Et Rhizoma Rhei (parched) composition, it is characterized in that the component composition (weight ratio) of this medicine is: the summation that the Radix Astragali 5.3~16.0% ZANGYINCHEN 5.3~16.0% Radix Salviae Miltiorrhizaes 5.3~13.3% Radix Paeoniae Rubra 2.7~13.3% Rhizoma Atractylodis Macrocephalaes 5.3~10.7% Carapax Trionycis pearls 5.3~10.7% Rhizoma sagittariae sagittifoliaes 5.3~10.7% OYSTER EXTRACT CAPSULE 5.3~10.7% Rhizoma Polygoni Cuspidati 5.3~10.7% Polyporus 2.7~5.3% long-pending real 2.7~5.3% Rhizoma Cyperis, 2.7~5.3% Radix Angelicae Sinensis, 1.8~5.3% Radix Bupleuri, 1.8~2.7% Semen Persicaes, 1.8~2.7% Colla Corii Asini, 1.8~2.7% eupolyphaga 1.8~2.7% are fried Semen Pharbitidis 1.8~2.7% Radix Et Rhizoma Rhei (parched) 0.9~2.7% each component is 100%.
2, the Chinese medicine for the treatment of cirrhosis according to claim 1 is characterized in that this medicine contains (weight ratio): black ugly 2.0~2.5% rhubarb,torrefieds, 1.5~2.1% each the component summation of the Radix Astragali 8.6~12.6% Tibetan oriental wormwoods, 8.6~12.6% reds sage root 7.0~11.0% radix paeoniae rubrathe, 6.0~9.0% bighead atractylodes rhizomes 6.5~9.5% turtle shell pearls, 6.5~9.5% arrowheads 6.5~9.5% OYSTER EXTRACT CAPSULEs, 6.5~9.5% giant knotweeds 6.5~9.5% umbellate pore furgus, 3.5~4.5% long-pending real 3.5~4.5% rhizoma cyperis 3.5~4.5% Radix Angelicae Sinensis, 3.2~4.0% radix bupleuri 2.0~2.5% peach kernels, 2.0~2.5% donkey-hide gelatin 2.0~2.5% soil units, 2.0~2.5% stir-frys are 100%.
CN98105026A 1998-01-25 1998-01-25 Medicine for treating cirrhosis Pending CN1192369A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN98105026A CN1192369A (en) 1998-01-25 1998-01-25 Medicine for treating cirrhosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN98105026A CN1192369A (en) 1998-01-25 1998-01-25 Medicine for treating cirrhosis

Publications (1)

Publication Number Publication Date
CN1192369A true CN1192369A (en) 1998-09-09

Family

ID=5218646

Family Applications (1)

Application Number Title Priority Date Filing Date
CN98105026A Pending CN1192369A (en) 1998-01-25 1998-01-25 Medicine for treating cirrhosis

Country Status (1)

Country Link
CN (1) CN1192369A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100413518C (en) * 2005-03-23 2008-08-27 刘朝辉 Capsule for treating cirrhosis ascites and its preparation technology

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100413518C (en) * 2005-03-23 2008-08-27 刘朝辉 Capsule for treating cirrhosis ascites and its preparation technology

Similar Documents

Publication Publication Date Title
CN100384467C (en) Traditional Chinese medicine composition for treating hepatitis and fatty liver
CN102488850B (en) Traditional Chinese medicinal composition for treating alcoholic fatty liver and preparation method thereof
CN102319407B (en) Traditional Chinese medicine for treating gastroptosis and extraction method thereof
CN1194843A (en) Method for producing green health medicine
CN102319408B (en) Chinese medicine for strengthening spleen, eliminating dampness and treating gastroptosis and extraction method thereof
CN103301412A (en) Traditional Chinese medicine composition for treating alcoholic liver
CN104083727A (en) Traditional Chinese medicine composition for nourishing and protecting liver
WO2022227331A1 (en) Composition for preventing rheumatoid arthritis, preparation method therefor, and application thereof
CN103977361A (en) Traditional Chinese medicine for treating ascites caused by cirrhosis and preparation method thereof
CN102397372A (en) Medicinal composition and pharmaceutical preparation and application thereof to treating irritable bowel syndrome
CN101011562B (en) Novel formulation of shenqiwendan decoction and production method thereof
CN101112591A (en) Medicine for treating cirrhosis and production process thereof
CN108042766A (en) A kind of Bushen Tongluo supports brain cream and preparation method thereof
CN102526230B (en) Traditional Chinese composition for curing liver disease and preparation method, quality detection method and application thereof
CN102327572B (en) Chinese medicament for invigorating primordial energy and treating gastroptosis and extraction method thereof
CN104524159A (en) Pharmaceutical composition for treating hyperplasia of mammary glands
CN104740521B (en) Preparation method of Ganfule soft capsule
CN1422643A (en) Oral pill for treating lupus erythematosus
CN104523873A (en) Pharmaceutical composition for treating gout
CN1192369A (en) Medicine for treating cirrhosis
CN101199697B (en) Nourishing kidney expellant medicament
CN114699498A (en) Pharmaceutical composition for resisting chronic hepatitis B and application thereof
CN104740520B (en) Ganfule soft capsule and preparation method thereof
CN102058765A (en) Chinese medicine preparation for treating cirrhosis and preparation method thereof
CN1814250B (en) Chinese medicine composition for treating liver cirrhosis ascites and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication